These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16977278)

  • 1. Is it safe to try new drugs when they first come on the market?
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):10. PubMed ID: 16977278
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].
    Johannesson M; Berglund EG
    Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388
    [No Abstract]   [Full Text] [Related]  

  • 3. A risk we have to swallow: can we ever be sure that medicines are safe before they hit the market?
    Matthews R
    New Sci; 2005 Mar 5-11; 185(2489):23. PubMed ID: 15839012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs for adults--and for the children?].
    Kalikstad B; Gramstad L
    Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1470. PubMed ID: 15940308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Projection and evaluation of clinical toxicity of new drugs].
    Adami E; Fresia P
    Arch Ital Sci Farmacol; 1964 Apr; 14(2):200-13. PubMed ID: 5320792
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical use and outcomes in children.
    Mullins CD
    Clin Ther; 2009 Feb; 31(2):420. PubMed ID: 19302914
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to read reports on clinical trials of drugs. II].
    Horácek J
    Cas Lek Cesk; 1986 Jul; 125(27):835-6. PubMed ID: 3731219
    [No Abstract]   [Full Text] [Related]  

  • 8. Adolescents in clinical trials.
    Kapogiannis BG; Mattison DR
    Clin Pharmacol Ther; 2008 Dec; 84(6):655-9. PubMed ID: 19008903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs: to use or not to use.
    Pepper GA
    Nurse Pract; 1985 Feb; 10(2):37, 41-2. PubMed ID: 3883249
    [No Abstract]   [Full Text] [Related]  

  • 10. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS; Greenberg HE; Reed MD;
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract]   [Full Text] [Related]  

  • 11. Microdosing: the new pharmacokinetic paradigm?
    Zanni GR; Wick JY
    Consult Pharm; 2006 Oct; 21(10):756-76. PubMed ID: 17243857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grapefruit-drug interactions: can interactions with drugs be avoided?
    Mertens-Talcott SU; Zadezensky I; De Castro WV; Derendorf H; Butterweck V
    J Clin Pharmacol; 2006 Dec; 46(12):1390-416. PubMed ID: 17101740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 14. [Children on the drug development map. The Danish Society of Clinical Pharmacology].
    Thirstrup S; Heisterberg J;
    Ugeskr Laeger; 2008 Mar; 170(12):1039. PubMed ID: 18397657
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental drugs: where do you stand legally?
    Marchette L
    RN; 1984 Mar; 47(3):23-4. PubMed ID: 6366999
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical issues of clinical trials in children: a European perspective.
    Sammons H
    Arch Dis Child; 2009 Jun; 94(6):474-7. PubMed ID: 19208673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensation for medicine-induced injury in clinical trials.
    Maling TJ
    N Z Med J; 1987 Apr; 100(821):223. PubMed ID: 3455486
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug load in clinical trials: a neglected factor.
    Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO
    Clin Pharmacol Ther; 1997 Dec; 62(6):592-5. PubMed ID: 9433387
    [No Abstract]   [Full Text] [Related]  

  • 19. Influences on the prescribing of new drugs.
    Tobin L; de Almedia Neto AC; Wutzke S; Patterson C; Mackson J; Weekes L; Williamson M
    Aust Fam Physician; 2008; 37(1-2):78-80, 83. PubMed ID: 18239759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature.
    Grootendorst P; Piérard E; Shim M
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):353-64. PubMed ID: 19670996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.